Armistice Capital, Vanguard, and Wellington Take Positions on PTC Therapeutics’ Rare-Disease Pipeline
Major institutional investors continue building exposure to PTC Therapeutics Inc. (NASDAQ: PTCT). The biopharmaceutical company is advancing its rare-disease pipeline ...









